It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2020.
2020 | Mumbai, Maharashtra, India | ActiveAgnodice Pharmaceuticals Private Limited, a active private limited company, was established on 06 May 2020 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24304MH2020PTC339655. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Its leadership includes Mayur Rajnikant Dalal (Director), Pratibha Mayur Dalal (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at A - 408A, Floor 4, Plot 711 A, Byculla Services Industries, Dadoji Konddeo Road, Ghodapdeo, Byculla (E),, Mumbai, Maharashtra, 400027.
U24304MH2020PTC339655
339655
06 May 2020
₹1.00 M
₹1.00 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Agnodice Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mayur Rajnikant Dalal | Director | 06 May 2020 | Current |
| Pratibha Mayur Dalal | Director | 06 May 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Agnodice Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Agnodice Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Agnodice Pharmaceuticals has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Agnodice Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agnodice Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Agnodice Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Agnodice Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
The activity Mayur Rajnikant Dalal was appointed as a Director was appointed as a Director on 06 May 2020 & has been associated with this company since 5 years 7 months . was completed.
Progress on Pratibha Mayur Dalal was appointed as a Director was appointed as a Director on 06 May 2020 & has been associated with this company since 5 years 7 months . was documented.
The activity Agnodice Pharmaceuticals Private Limited was registered on 06 May 2020 with Roc Mumbai & aged 5 years 7 months as per MCA records. was completed.
The CIN of Agnodice Pharmaceuticals Private Limited is U24304MH2020PTC339655.
Agnodice Pharmaceuticals Private Limited is headquartered at A - 408A, Floor 4, Plot 711 A, Byculla Services Industries, Dadoji Konddeo Road, Ghodapdeo, Byculla (E),, Mumbai, Maharashtra, 400027.
Agnodice Pharmaceuticals Private Limited was incorporated on 06 May 2020.
The current directors of Agnodice Pharmaceuticals Private Limited are
The primary industry of Agnodice Pharmaceuticals Private Limited is Pharma.
Agnodice Pharmaceuticals Private Limited is unlisted.
The authorized capital of Agnodice Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX